Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Open accessThe DOI matches its Crossref record; 1,028 of the 1,028 references it cites were found in a registry or an index.
Abstract
Cancer remains a significant risk to human health. Nanomedicine is a new multidisciplinary field that is garnering a lot of interest and investigation. Nanomedicine shows great potential for cancer diagnosis and treatment. Specifically engineered nanoparticles can be employed as contrast agents in cancer diagnostics to enable high sensitivity and high-resolution tumor detection by imaging examinations. Novel approaches for tumor labeling and detection are also made possible by the use of nanoprobes and nanobiosensors. The achievement of targeted medication delivery in cancer therapy can be accomplished through the rational design and manufacture of nanodrug carriers. Nanoparticles have the capability to effectively transport medications or gene fragments to tumor tissues via passive or active targeting processes, thus enhancing treatment outcomes while minimizing harm to healthy tissues. Simultaneously, nanoparticles can be employed in the context of radiation sensitization and photothermal therapy to enhance the therapeutic efficacy of malignant tumors. This review presents a literature overview and summary of how nanotechnology is used in the diagnosis and treatment of malignant tumors. According to oncological diseases originating from different systems of the body and combining the pathophysiological features of cancers at different sites, we review the most recent developments in nanotechnology applications. Finally, we briefly discuss the prospects and challenges of nanotechnology in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 201–400 of 1,028
Yan, W., Wu, X., Zhou, W., Fong, M. Y., Cao, M., Liu, J., Liu, X., Chen, C.-H., Fadare, O., Pizzo, D. P., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0083-6 · Cited by 469
Biomaterial-assisted targeted modulation of immune cells in cancer treatment
Wang, H., & Mooney, D. J. (2018) · Nature Materials · doi:10.1038/s41563-018-0147-9 · Cited by 467
Self-citationRecent progress in nanomedicine for enhanced cancer chemotherapy
Wei, G., Wang, Y., Yang, G., Wang, Y., & Ju, R. (2021) · Theranostics · doi:10.7150/thno.57828 · Cited by 463
Clinical translation of nanomedicines: Challenges, opportunities, and keys
Younis, M. A., Tawfeek, H. M., Abdellatif, A. A. H., Abdel-Aleem, J. A., & Harashima, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114083 · Cited by 462
Cheng, L., Albers, P., Berney, D. M., Feldman, D. R., Daugaard, G., Gilligan, T., & Looijenga, L. H. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0029-0 · Cited by 462
Comstock, C. E., Gatsonis, C., Newstead, G. M., Snyder, B. S., Gareen, I. F., Bergin, J. T., Rahbar, H., Sung, J. S., Jacobs, C., Harvey, J. A., et al. (2020) · JAMA · doi:10.1001/jama.2020.0572 · Cited by 456
Biomimetic proteolipid vesicles for targeting inflamed tissues
Molinaro, R., Corbo, C., Martinez, J. O., Taraballi, F., Evangelopoulos, M., Minardi, S., Yazdi, I. K., Zhao, P., De Rosa, E., Sherman, M. B., et al. (2016) · Nature Materials · doi:10.1038/nmat4644 · Cited by 451
NIR-II nanoprobes in-vivo assembly to improve image-guided surgery for metastatic ovarian cancer
Wang, P., Fan, Y., Lu, L., Liu, L., Fan, L., Zhao, M., Xie, Y., Xu, C., & Zhang, F. (2018) · Nature Communications · doi:10.1038/s41467-018-05113-8 · Cited by 451
Conde, J., Oliva, N., Zhang, Y., & Artzi, N. (2016) · Nature Materials · doi:10.1038/nmat4707 · Cited by 449
Zhang, L., Wang, Z., Zhang, Y., Cao, F., Dong, K., Ren, J., & Qu, X. (2018) · ACS Nano · doi:10.1021/acsnano.8b05200 · Cited by 446
Obstacles and opportunities in a forward vision for cancer nanomedicine
de Lázaro, I., & Mooney, D. J. (2021) · Nature Materials · doi:10.1038/s41563-021-01047-7 · Cited by 439
Wolfram, J., & Ferrari, M. (2019) · Nano Today · doi:10.1016/j.nantod.2019.02.005 · Cited by 436
Priorities for cancer research in low- and middle-income countries: a global perspective
Pramesh, C. S., Badwe, R. A., Bhoo-Pathy, N., Booth, C. M., Chinnaswamy, G., Dare, A. J., de Andrade, V. P., Hunter, D. J., Gopal, S., Gospodarowicz, M., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01738-x · Cited by 434
The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives
Sun, R., Xiang, J., Zhou, Q., Piao, Y., Tang, J., Shao, S., Zhou, Z., Bae, Y. H., & Shen, Y. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114614 · Cited by 433
Platelet membrane-camouflaged magnetic nanoparticles for ferroptosis-enhanced cancer immunotherapy
Jiang, Q., Wang, K., Zhang, X., Ouyang, B., Liu, H., Pang, Z., & Yang, W. (2020) · Small · doi:10.1002/smll.202001704 · Cited by 426
Self-citationTian, H., Zhang, T., Qin, S., Huang, Z., Zhou, L., Shi, J., Nice, E. C., Xie, N., Huang, C., & Shen, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01320-5 · Cited by 426
Cutaneous Squamous Cell Carcinoma
Waldman, A., & Schmults, C. (2019) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.08.001 · Cited by 424
Epigenetics in cancer stem cells
Toh, T. B., Lim, J. J., & Chow, E. K.-H. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0596-9 · Cited by 422
DNAzyme‐Loaded Metal–Organic Frameworks (MOFs) for Self‐Sufficient Gene Therapy
Wang, H., Chen, Y., Wang, H., Liu, X., Zhou, X., & Wang, F. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201902714 · Cited by 417
Self-citationInjectable cryogel-based whole-cell cancer vaccines
Bencherif, S. A., Warren Sands, R., Ali, O. A., Li, W. A., Lewin, S. A., Braschler, T. M., Shih, T.-Y., Verbeke, C. S., Bhatta, D., Dranoff, G., et al. (2015) · Nature Communications · doi:10.1038/ncomms8556 · Cited by 416
Polysaccharide-based nanoparticles for theranostic nanomedicine
Swierczewska, M., Han, H. S., Kim, K., Park, J. H., & Lee, S. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.015 · Cited by 415
MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies
Kim, T., & Croce, C. M. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01050-9 · Cited by 407
Bhatia, S. N., Chen, X., Dobrovolskaia, M. A., & Lammers, T. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00496-9 · Cited by 406
Jiang, Q., Liu, Y., Guo, R., Yao, X., Sung, S., Pang, Z., & Yang, W. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.11.021 · Cited by 398
The Exosome Total Isolation Chip
Liu, F., Vermesh, O., Mani, V., Ge, T. J., Madsen, S. J., Sabour, A., Hsu, E.-C., Gowrishankar, G., Kanada, M., Jokerst, J. V., et al. (2017) · ACS Nano · doi:10.1021/acsnano.7b04878 · Cited by 396
CXCL12 (SDF1α)-CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anticancer Therapies?
Duda, D. G., Kozin, S. V., Kirkpatrick, N. D., Xu, L., Fukumura, D., & Jain, R. K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2636 · Cited by 395
Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Glioma
Fan, K., Jia, X., Zhou, M., Wang, K., Conde, J., He, J., Tian, J., & Yan, X. (2018) · ACS Nano · doi:10.1021/acsnano.7b06969 · Cited by 395
Self-citationOsteosarcoma: Anatomic and Histologic Variants
Klein, M. J., & Siegal, G. P. (2006) · American Journal of Clinical Pathology · doi:10.1309/uc6kqhld9lv2kenn · Cited by 386
Bridging Bio–Nano Science and Cancer Nanomedicine
Björnmalm, M., Thurecht, K. J., Michael, M., Scott, A. M., & Caruso, F. (2017) · ACS Nano · doi:10.1021/acsnano.7b04855 · Cited by 382
Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma
Furnari, F. B., Cloughesy, T. F., Cavenee, W. K., & Mischel, P. S. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3918 · Cited by 381
Contemporary radiotherapy: present and future
Chandra, R. A., Keane, F. K., Voncken, F. E. M., & Thomas, C. R. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00233-6 · Cited by 380
Kou, S. (., Peters, L., & Mucalo, M. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119132 · Cited by 380
Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening
Yeh, T.-H., Hsu, L.-W., Tseng, M. T., Lee, P.-L., Sonjae, K., Ho, Y.-C., & Sung, H.-W. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.056 · Cited by 379
Designing Hydrogels for On-Demand Therapy
Oliva, N., Conde, J., Wang, K., & Artzi, N. (2017) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6b00536 · Cited by 371
Self-citationLi, S., Deng, Q., Zhang, Y., Li, X., Wen, G., Cui, X., Wan, Y., Huang, Y., Chen, J., Liu, Z., et al. (2020) · Advanced Materials · doi:10.1002/adma.202001146 · Cited by 369
Self-citationMegyesfalvi, Z., Gay, C. M., Popper, H., Pirker, R., Ostoros, G., Heeke, S., Lang, C., Hoetzenecker, K., Schwendenwein, A., Boettiger, K., et al. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21785 · Cited by 369
Bellavia, D., Raimondo, S., Calabrese, G., Forte, S., Cristaldi, M., Patinella, A., Memeo, L., Manno, M., Raccosta, S., Diana, P., et al. (2017) · Theranostics · doi:10.7150/thno.17092 · Cited by 368
Klein, M. J., & Siegal, G. P. (2006) · American Journal of Clinical Pathology · doi:10.1309/uc6k-qhld-9lv2-kenn · Cited by 367
Pei, Q., Hu, X., Zheng, X., Liu, S., Li, Y., Jing, X., & Xie, Z. (2018) · ACS Nano · doi:10.1021/acsnano.7b08219 · Cited by 366
Advancements in nanoparticle-based treatment approaches for skin cancer therapy
Zeng, L., Gowda, B. H. J., Ahmed, M. G., Abourehab, M. A. S., Chen, Z.-S., Zhang, C., Li, J., & Kesharwani, P. (2023) · Molecular Cancer · doi:10.1186/s12943-022-01708-4 · Cited by 365
Targeted gene silencing in vivo by platelet membrane–coated metal-organic framework nanoparticles
Zhuang, J., Gong, H., Zhou, J., Zhang, Q., Gao, W., Fang, R. H., & Zhang, L. (2020) · Science Advances · doi:10.1126/sciadv.aaz6108 · Cited by 363
Lu, Z., Zuo, B., Jing, R., Gao, X., Rao, Q., Liu, Z., Qi, H., Guo, H., & Yin, H. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.019 · Cited by 361
Self-citationZhong, R., Talebian, S., Mendes, B. B., Wallace, G., Langer, R., Conde, J., & Shi, J. (2023) · Nature Materials · doi:10.1038/s41563-023-01472-w · Cited by 360
pH-Sensitive ZnO Quantum Dots–Doxorubicin Nanoparticles for Lung Cancer Targeted Drug Delivery
Cai, X., Luo, Y., Zhang, W., Du, D., & Lin, Y. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b04933 · Cited by 359
Han, L., & Jiang, C. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.11.023 · Cited by 358
Kim, S. Y., An, J., Lim, Y.-S., Han, S., Lee, J.-Y., Byun, J. H., Won, H. J., Lee, S. J., Lee, H. C., & Lee, Y. S. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.3147 · Cited by 356
Liang, C., Guo, B., Wu, H., Shao, N., Li, D., Liu, J., Dang, L., Wang, C., Li, H., Li, S., et al. (2015) · Nature Medicine · doi:10.1038/nm.3791 · Cited by 354
Self-citationMechanical Force-Triggered Drug Delivery
Zhang, Y., Yu, J., Bomba, H. N., Zhu, Y., & Gu, Z. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00369 · Cited by 354
Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy
Han, X., Shen, S., Fan, Q., Chen, G., Archibong, E., Dotti, G., Liu, Z., Gu, Z., & Wang, C. (2019) · Science Advances · doi:10.1126/sciadv.aaw6870 · Cited by 349
Polymer–drug conjugates: Origins, progress to date and future directions
Kopeček, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.014 · Cited by 347
Kumthekar, P., Ko, C. H., Paunesku, T., Dixit, K., Sonabend, A. M., Bloch, O., Tate, M., Schwartz, M., Zuckerman, L., Lezon, R., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb3945 · Cited by 345
Han, X., Li, Y., Xu, Y., Zhao, X., Zhang, Y., Yang, X., Wang, Y., Zhao, R., Anderson, G. J., Zhao, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05906-x · Cited by 339
Self-citationExtracellular vesicles versus synthetic nanoparticles for drug delivery
Witwer, K. W., & Wolfram, J. (2021) · Nature Reviews Materials · doi:10.1038/s41578-020-00277-6 · Cited by 337
Gold nanoparticles and gold nanorods in the landscape of cancer therapy
Kesharwani, P., Ma, R., Sang, L., Fatima, M., Sheikh, A., Abourehab, M. A. S., Gupta, N., Chen, Z.-S., & Zhou, Y. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01798-8 · Cited by 337
Gold nanoclusters-assisted delivery of NGF siRNA for effective treatment of pancreatic cancer
Lei, Y., Tang, L., Xie, Y., Xianyu, Y., Zhang, L., Wang, P., Hamada, Y., Jiang, K., Zheng, W., & Jiang, X. (2017) · Nature Communications · doi:10.1038/ncomms15130 · Cited by 336
Li, L., Tang, F., Liu, H., Liu, T., Hao, N., Chen, D., Teng, X., & He, J. (2010) · ACS Nano · doi:10.1021/nn100918a · Cited by 332
Red blood cell membrane-camouflaged melanin nanoparticles for enhanced photothermal therapy
Jiang, Q., Luo, Z., Men, Y., Yang, P., Peng, H., Guo, R., Tian, Y., Pang, Z., & Yang, W. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.027 · Cited by 332
Strategies to improve the EPR effect: A mechanistic perspective and clinical translation
Ikeda-Imafuku, M., Wang, L. L.-W., Rodrigues, D., Shaha, S., Zhao, Z., & Mitragotri, S. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.043 · Cited by 330
Boca, S. C., Potara, M., Gabudean, A.-M., Juhem, A., Baldeck, P. L., & Astilean, S. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.06.022 · Cited by 325
A modular platform for targeted RNAi therapeutics
Kedmi, R., Veiga, N., Ramishetti, S., Goldsmith, M., Rosenblum, D., Dammes, N., Hazan-Halevy, I., Nahary, L., Leviatan-Ben-Arye, S., Harlev, M., et al. (2018) · Nature Nanotechnology · doi:10.1038/s41565-017-0043-5 · Cited by 320
FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels
Trujillo-Alonso, V., Pratt, E. C., Zong, H., Lara-Martinez, A., Kaittanis, C., Rabie, M. O., Longo, V., Becker, M. W., Roboz, G. J., Grimm, J., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0406-1 · Cited by 319
Wei, H., Chen, J., Wang, S., Fu, F., Zhu, X., Wu, C., Liu, Z., Zhong, G., & Lin, J. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s218988 · Cited by 317
Kong, N., Tao, W., Ling, X., Wang, J., Xiao, Y., Shi, S., Ji, X., Shajii, A., Gan, S. T., Kim, N. Y., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw1565 · Cited by 314
Yang, R. S. H., Chang, L. W., Wu, J.-P., Tsai, M.-H., Wang, H.-J., Kuo, Y.-C., Yeh, T.-K., Yang, C. S., & Lin, P. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10290 · Cited by 314
Self-citationSong, W., Kuang, J., Li, C.-X., Zhang, M., Zheng, D., Zeng, X., Liu, C., & Zhang, X.-Z. (2018) · ACS Nano · doi:10.1021/acsnano.7b09112 · Cited by 314
Sancho-Albero, M., Rubio-Ruiz, B., Pérez-López, A. M., Sebastián, V., Martín-Duque, P., Arruebo, M., Santamaría, J., & Unciti-Broceta, A. (2019) · Nature Catalysis · doi:10.1038/s41929-019-0333-4 · Cited by 310
Wei, X., Shao, B., He, Z., Ye, T., Luo, M., Sang, Y., Liang, X., Wang, W., Luo, S., Yang, S., et al. (2015) · Cell Research · doi:10.1038/cr.2015.9 · Cited by 306
Xuan, M., Shao, J., Zhao, J., Li, Q., Dai, L., & Li, J. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201712996 · Cited by 305
DNA hydrogel-based gene editing and drug delivery systems
Mo, F., Jiang, K., Zhao, D., Wang, Y., Song, J., & Tan, W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.018 · Cited by 304
Challenges in glioblastoma research: focus on the tumor microenvironment
Bikfalvi, A., da Costa, C. A., Avril, T., Barnier, J.-V., Bauchet, L., Brisson, L., Cartron, P. F., Castel, H., Chevet, E., Chneiweiss, H., et al. (2023) · Trends in Cancer · doi:10.1016/j.trecan.2022.09.005 · Cited by 302
Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy
Galstyan, A., Markman, J. L., Shatalova, E. S., Chiechi, A., Korman, A. J., Patil, R., Klymyshyn, D., Tourtellotte, W. G., Israel, L. L., Braubach, O., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11719-3 · Cited by 300
Nanotechnological carriers for cancer chemotherapy: The state of the art
Estanqueiro, M., Amaral, M. H., Conceição, J., & Sousa Lobo, J. M. (2015) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2014.12.041 · Cited by 298
NCCN Guidelines Insights: Bone Cancer, Version 2.2017
Biermann, J. S., Chow, W., Reed, D. R., Lucas, D., Adkins, D. R., Agulnik, M., Benjamin, R. S., Brigman, B., Budd, G. T., Curry, W. T., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0017 · Cited by 294
Park, S. J. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s254808 · Cited by 293
Norouzi, M., Yathindranath, V., Thliveris, J. A., Kopec, B. M., Siahaan, T. J., & Miller, D. W. (2020) · Scientific Reports · doi:10.1038/s41598-020-68017-y · Cited by 292
Chen, C., Jing, W., Chen, Y., Wang, G., Abdalla, M., Gao, L., Han, M., Shi, C., Li, A., Sun, P., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abn1128 · Cited by 291
Recent advances in nanoparticle-based photothermal therapy for breast cancer
Alamdari, S. G., Amini, M., Jalilzadeh, N., Baradaran, B., Mohammadzadeh, R., Mokhtarzadeh, A., & Oroojalian, F. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.06.050 · Cited by 290
Fenton, O. S., Kauffman, K. J., Kaczmarek, J. C., McClellan, R. L., Jhunjhunwala, S., Tibbitt, M. W., Zeng, M. D., Appel, E. A., Dorkin, J. R., Mir, F. F., et al. (2017) · Advanced Materials · doi:10.1002/adma.201606944 · Cited by 288
Targeting 3D Bladder Cancer Spheroids with Urease-Powered Nanomotors
Hortelão, A. C., Carrascosa, R., Murillo-Cremaes, N., Patiño, T., & Sánchez, S. (2019) · ACS Nano · doi:10.1021/acsnano.8b06610 · Cited by 287
Engineered nanomedicine for myeloma and bone microenvironment targeting
Swami, A., Reagan, M. R., Basto, P., Mishima, Y., Kamaly, N., Glavey, S., Zhang, S., Moschetta, M., Seevaratnam, D., Zhang, Y., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401337111 · Cited by 283
Ni, Q., Zhang, F., Liu, Y., Wang, Z., Yu, G., Liang, B., Niu, G., Su, T., Zhu, G., Lu, G., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaw6071 · Cited by 281
Chitosan based bioadhesives for biomedical applications: A review
Hamedi, H., Moradi, S., Hudson, S. M., Tonelli, A. E., & King, M. W. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119100 · Cited by 281
Biosensing with Fluorescent Carbon Nanotubes
Ackermann, J., Metternich, J. T., Herbertz, S., & Kruss, S. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202112372 · Cited by 280
Bai, R., Li, Y., Jian, L., Yang, Y., Zhao, L., & Wei, M. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01645-2 · Cited by 279
Advances in the clinical management of uveal melanoma
Carvajal, R. D., Sacco, J. J., Jager, M. J., Eschelman, D. J., Olofsson Bagge, R., Harbour, J. W., Chieng, N. D., Patel, S. P., Joshua, A. M., & Piperno-Neumann, S. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00714-1 · Cited by 278
Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions
Banfill, K., Giuliani, M., Aznar, M., Franks, K., McWilliam, A., Schmitt, M., Sun, F., Vozenin, M. C., & Faivre Finn, C. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.11.002 · Cited by 272
Krug, A. K., Enderle, D., Karlovich, C., Priewasser, T., Bentink, S., Spiel, A., Brinkmann, K., Emenegger, J., Grimm, D. G., Castellanos-Rizaldos, E., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdx765 · Cited by 271
Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers
Kim, J., Bamlet, W. R., Oberg, A. L., Chaffee, K. G., Donahue, G., Cao, X.-J., Chari, S., Garcia, B. A., Petersen, G. M., & Zaret, K. S. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah5583 · Cited by 269
Rosalia, R. A., Cruz, L. J., van Duikeren, S., Tromp, A. T., Silva, A. L., Jiskoot, W., de Gruijl, T., Löwik, C., Oostendorp, J., van der Burg, S. H., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.053 · Cited by 269
Cheng, W., Liang, C., Xu, L., Liu, G., Gao, N., Tao, W., Luo, L., Zuo, Y., Wang, X., Zhang, X., et al. (2017) · Small · doi:10.1002/smll.201700623 · Cited by 269
Zi, Y., Yang, K., He, J., Wu, Z., Liu, J., & Zhang, W. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114449 · Cited by 268
Ali, E. S., Sharker, S. M., Islam, M. T., Khan, I. N., Shaw, S., Rahman, M. A., Uddin, S. J., Shill, M. C., Rehman, S., Das, N., et al. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.01.011 · Cited by 267
Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery
Parodi, A., Molinaro, R., Sushnitha, M., Evangelopoulos, M., Martinez, J. O., Arrighetti, N., Corbo, C., & Tasciotti, E. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.020 · Cited by 266
Cancer nanotechnology: current status and perspectives
Kemp, J. A., & Kwon, Y. J. (2021) · Nano Convergence · doi:10.1186/s40580-021-00282-7 · Cited by 266
Yuan, Y., Zhang, C., & Liu, B. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201503640 · Cited by 265
Nanomachines and Other Caps on Mesoporous Silica Nanoparticles for Drug Delivery
Chen, W., Glackin, C. A., Horwitz, M. A., & Zink, J. I. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00116 · Cited by 264
Red blood cell membrane camouflaged magnetic nanoclusters for imaging-guided photothermal therapy
Ren, X., Zheng, R., Fang, X., Wang, X., Zhang, X., Yang, W., & Sha, X. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.03.026 · Cited by 260
Messerschmitt, P. J., Garcia, R. M., Abdul-Karim, F. W., Greenfield, E. M., & Getty, P. J. (2009) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/00124635-200908000-00005 · Cited by 260
Walker, M. D., & Shane, E. (2022) · JAMA · doi:10.1001/jama.2022.18331 · Cited by 260
Treatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259
Dogra, P., Adolphi, N. L., Wang, Z., Lin, Y.-S., Butler, K. S., Durfee, P. N., Croissant, J. G., Noureddine, A., Coker, E. N., Bearer, E. L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06730-z · Cited by 257
Circulating miRNA panels for specific and early detection in bladder cancer
Usuba, W., Urabe, F., Yamamoto, Y., Matsuzaki, J., Sasaki, H., Ichikawa, M., Takizawa, S., Aoki, Y., Niida, S., Kato, K., et al. (2019) · Cancer Science · doi:10.1111/cas.13856 · Cited by 257
Frontiers in the treatment of glioblastoma: Past, present and emerging
Janjua, T. I., Rewatkar, P., Ahmed-Cox, A., Saeed, I., Mansfeld, F. M., Kulshreshtha, R., Kumeria, T., Ziegler, D. S., Kavallaris, M., Mazzieri, R., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.012 · Cited by 257
Mekaru, H., Lu, J., & Tamanoi, F. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.009 · Cited by 256
Huang, K.-W., Hsu, F.-F., Qiu, J. T., Chern, G.-J., Lee, Y.-A., Chang, C.-C., Huang, Y.-T., Sung, Y.-C., Chiang, C.-C., Huang, R.-L., et al. (2020) · Science Advances · doi:10.1126/sciadv.aax5032 · Cited by 256
Simpson, R. C., Shanahan, E. R., Batten, M., Reijers, I. L. M., Read, M., Silva, I. P., Versluis, J. M., Ribeiro, R., Angelatos, A. S., Tan, J., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01965-2 · Cited by 256
Bioactive inorganic nanomaterials for cancer theranostics
Pei, Z., Lei, H., & Cheng, L. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00352j · Cited by 255
The blood clearance kinetics and pathway of polymeric micelles in cancer drug delivery
Sun, X., Wang, G., Zhang, H., Hu, S., Liu, X., Tang, J., & Shen, Y. (2018) · ACS Nano · doi:10.1021/acsnano.8b02830 · Cited by 253
Immune Cell-Derived Extracellular Vesicles – Functions and Therapeutic Applications
Veerman, R. E., Güçlüler Akpinar, G., Eldh, M., & Gabrielsson, S. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.02.003 · Cited by 251
IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment
Karakasheva, T. A., Lin, E. W., Tang, Q., Qiao, E., Waldron, T. J., Soni, M., Klein-Szanto, A. J., Sahu, V., Basu, D., Ohashi, S., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2268 · Cited by 250
Cancer nanomedicine toward clinical translation: Obstacles, opportunities, and future prospects
Zhang, P., Xiao, Y., Sun, X., Lin, X., Koo, S., Yaremenko, A. V., Qin, D., Kong, N., Farokhzad, O. C., & Tao, W. (2023) · Med · doi:10.1016/j.medj.2022.12.001 · Cited by 249
Katlinski, K. V., Gui, J., Katlinskaya, Y. V., Ortiz, A., Chakraborty, R., Bhattacharya, S., Carbone, C. J., Beiting, D. P., Girondo, M. A., Peck, A. R., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.004 · Cited by 248
Zhang, Y., Li, N., Suh, H., & Irvine, D. J. (2018) · Nature Communications · doi:10.1038/s41467-017-02251-3 · Cited by 248
Management of metastatic bladder cancer
Nadal, R., & Bellmunt, J. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2019.04.002 · Cited by 247
Shin, H., Jeong, H., Park, J., Hong, S., & Choi, Y. (2018) · ACS Sensors · doi:10.1021/acssensors.8b01047 · Cited by 246
Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis
Poon, C. C., Sarkar, S., Yong, V. W., & Kelly, J. J. P. (2017) · Brain · doi:10.1093/brain/aww355 · Cited by 246
Nanotechnology intervention of the microbiome for cancer therapy
Song, W., Anselmo, A. C., & Huang, L. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0589-5 · Cited by 246
Molecular Biology of Lung Cancer: Clinical Implications
Larsen, J. E., & Minna, J. D. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.08.003 · Cited by 245
Magnetic iron oxide nanoparticles for brain imaging and drug delivery
Qiao, R., Fu, C., Forgham, H., Javed, I., Huang, X., Zhu, J., Whittaker, A. K., & Davis, T. P. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114822 · Cited by 245
Therapeutic advances in anaplastic thyroid cancer: a current perspective
Saini, S., Tulla, K., Maker, A. V., Burman, K. D., & Prabhakar, B. S. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0903-0 · Cited by 244
Thermal immuno-nanomedicine in cancer
Yang, Z., Gao, D., Zhao, J., Yang, G., Guo, M., Wang, Y., Ren, X., Kim, J. S., Jin, L., Tian, Z., et al. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00717-y · Cited by 242
Engineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and Thrombus
Hu, Q., Qian, C., Sun, W., Wang, J., Chen, Z., Bomba, H. N., Xin, H., Shen, Q., & Gu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201603463 · Cited by 240
Design of Nanocomposite Injectable Hydrogels for Minimally Invasive Surgery
Piantanida, E., Alonci, G., Bertucci, A., & De Cola, L. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00114 · Cited by 240
Yang, Y., Yu, Y., Chen, H., Meng, X., Ma, W., Yu, M., Li, Z., Li, C., Liu, H., Zhang, X., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c05541 · Cited by 240
Hom, C., Lu, J., Liong, M., Luo, H., Li, Z., Zink, J. I., & Tamanoi, F. (2010) · Small · doi:10.1002/smll.200901966 · Cited by 239
Jong, A. Y., Wu, C., Li, J., Sun, J., Fabbri, M., Wayne, A. S., & Seeger, R. C. (2017) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2017.1294368 · Cited by 239
Lang, F. M., Hossain, A., Gumin, J., Momin, E. N., Shimizu, Y., Ledbetter, D., Shahar, T., Yamashita, S., Parker Kerrigan, B., Fueyo, J., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/nox152 · Cited by 239
Exosomes and Nanoengineering: A Match Made for Precision Therapeutics
Tran, P. H. L., Xiang, D., Tran, T. T. D., Yin, W., Zhang, Y., Kong, L., Chen, K., Sun, M., Li, Y., Hou, Y., et al. (2020) · Advanced Materials · doi:10.1002/adma.201904040 · Cited by 236
Domingues, C., Santos, A., Alvarez-Lorenzo, C., Concheiro, A., Jarak, I., Veiga, F., Barbosa, I., Dourado, M., & Figueiras, A. (2022) · ACS Nano · doi:10.1021/acsnano.2c00128 · Cited by 235
Skin cancer biology and barriers to treatment: Recent applications of polymeric micro/nanostructures
Khan, N. H., Mir, M., Qian, L., Baloch, M., Ali Khan, M. F., Rehman, A.-U., Ngowi, E. E., Wu, D.-D., & Ji, X.-Y. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2021.06.014 · Cited by 234
Clinical Applications of Carbon Nanomaterials in Diagnostics and Therapy
Loh, K. P., Ho, D., Chiu, G. N. C., Leong, D. T., Pastorin, G., & Chow, E. K. (2018) · Advanced Materials · doi:10.1002/adma.201802368 · Cited by 232
Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
Tian, H., Cao, J., Li, B., Nice, E. C., Mao, H., Zhang, Y., & Huang, C. (2023) · Bone Research · doi:10.1038/s41413-023-00246-z · Cited by 232
Novel targeted therapies and immunotherapy for advanced thyroid cancers
Naoum, G. E., Morkos, M., Kim, B., & Arafat, W. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0786-0 · Cited by 230
Characterisation and manipulation of docetaxel resistant prostate cancer cell lines
O'Neill, A. J., Prencipe, M., Dowling, C., Fan, Y., Mulrane, L., Gallagher, W. M., O'Connor, D., O'Connor, R., Devery, A., Corcoran, C., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-126 · Cited by 229
Halley, P. D., Lucas, C. R., McWilliams, E. M., Webber, M. J., Patton, R. A., Kural, C., Lucas, D. M., Byrd, J. C., & Castro, C. E. (2016) · Small · doi:10.1002/smll.201502118 · Cited by 227
LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma
Zhang, B., Sun, X., Mei, H., Wang, Y., Liao, Z., Chen, J., Zhang, Q., Hu, Y., Pang, Z., & Jiang, X. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.039 · Cited by 225
Self-citationRNAi delivery by exosome-mimetic nanovesicles – Implications for targeting c-Myc in cancer
Lunavat, T. R., Jang, S. C., Nilsson, L., Park, H. T., Repiska, G., Lässer, C., Nilsson, J. A., Gho, Y. S., & Lötvall, J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.024 · Cited by 225
Lu, J., Li, Z., Zink, J. I., & Tamanoi, F. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.06.002 · Cited by 224
Mao, F., Wen, L., Sun, C., Zhang, S., Wang, G., Zeng, J., Wang, Y., Ma, J., Gao, M., & Li, Z. (2016) · ACS Nano · doi:10.1021/acsnano.6b06067 · Cited by 224
Nanotoxicity: challenging the myth of nano-specific toxicity
Donaldson, K., & Poland, C. A. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.05.003 · Cited by 221
Gao, G., Jiang, Y., Sun, W., Guo, Y., Jia, H., Yu, X., Pan, G., & Wu, F. (2019) · Small · doi:10.1002/smll.201900501 · Cited by 221
Li, M., Li, M., Yang, Y., Liu, Y., Xie, H., Yu, Q., Tian, L., Tang, X., Ren, K., Li, J., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.011 · Cited by 221
Tumor-derived exosomes: a new source of tumor rejection antigens
André, F., Schartz, N. E. C., Chaput, N., Flament, C., Raposo, G., Amigorena, S., Angevin, E., & Zitvogel, L. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00384-5 · Cited by 220
Durfee, P. N., Lin, Y.-S., Dunphy, D. R., Muñiz, A. J., Butler, K. S., Humphrey, K. R., Lokke, A. J., Agola, J. O., Chou, S. S., Chen, I.-M., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b02819 · Cited by 219
Dendrimers in combination with natural products and analogues as anti-cancer agents
Mignani, S., Rodrigues, J., Tomas, H., Zablocka, M., Shi, X., Caminade, A.-M., & Majoral, J.-P. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00550d · Cited by 219
Mesoporous Silica as a Versatile Platform for Cancer Immunotherapy
Nguyen, T. L., Choi, Y., & Kim, J. (2019) · Advanced Materials · doi:10.1002/adma.201803953 · Cited by 219
Mirza, Z., & Karim, S. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.10.020 · Cited by 219
Wang, H., Agarwal, P., Zhao, S., Xu, R. X., Yu, J., Lu, X., & He, X. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.08.048 · Cited by 218
Self-citationZheng, M., Liu, Y., Wang, Y., Zhang, D., Zou, Y., Ruan, W., Yin, J., Tao, W., Park, J. B., & Shi, B. (2019) · Advanced Materials · doi:10.1002/adma.201903277 · Cited by 217
Zhang, Y., Wang, F., Li, M., Yu, Z., Qi, R., Ding, J., Zhang, Z., & Chen, X. (2018) · Advanced Science · doi:10.1002/advs.201700821 · Cited by 215
Kim, M., Chen, C., Wang, P., Mulvey, J. J., Yang, Y., Wun, C., Antman-Passig, M., Luo, H.-B., Cho, S., Long-Roche, K., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00860-y · Cited by 214
Qiu, S., Xie, L., Lu, C., Gu, C., Xia, Y., Lv, J., Xuan, Z., Fang, L., Yang, J., Zhang, L., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02499-8 · Cited by 214
Exosome-Based Detection of EGFR T790M in Plasma from Non–Small Cell Lung Cancer Patients
Castellanos-Rizaldos, E., Grimm, D. G., Tadigotla, V., Hurley, J., Healy, J., Neal, P. L., Sher, M., Venkatesan, R., Karlovich, C., Raponi, M., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3369 · Cited by 213
Dong, Y., Yu, T., Ding, L., Laurini, E., Huang, Y., Zhang, M., Weng, Y., Lin, S., Chen, P., Marson, D., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b10021 · Cited by 213
High-Density Lipoprotein-Mimicking Nanodiscs for Chemo-immunotherapy against Glioblastoma Multiforme
Kadiyala, P., Li, D., Nuñez, F. M., Altshuler, D., Doherty, R., Kuai, R., Yu, M., Kamran, N., Edwards, M., Moon, J. J., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b06842 · Cited by 212
Ouyang, J., Sun, L., Zeng, Z., Zeng, C., Zeng, F., & Wu, S. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201913149 · Cited by 212
Molecular biology of lung cancer: Clinical implications
Fong, K. M., & Minna, J. D. (2002) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(03)00062-5 · Cited by 209
Choudhury, H., Pandey, M., Chin, P. X., Phang, Y. L., Cheah, J. Y., Ooi, S. C., Mak, K.-K., Pichika, M. R., Kesharwani, P., Hussain, Z., et al. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-018-0552-2 · Cited by 209
68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
Rauscher, I., Maurer, T., Fendler, W. P., Sommer, W. H., Schwaiger, M., & Eiber, M. (2016) · Cancer Imaging · doi:10.1186/s40644-016-0072-6 · Cited by 208
Recent Advances in Biosensors for Detecting Cancer-Derived Exosomes
Cheng, N., Du, D., Wang, X., Liu, D., Xu, W., Luo, Y., & Lin, Y. (2019) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.04.008 · Cited by 207
Ashrafizadeh, M., Zarrabi, A., Bigham, A., Taheriazam, A., Saghari, Y., Mirzaei, S., Hashemi, M., Hushmandi, K., Karimi‐Maleh, H., Nazarzadeh Zare, E., et al. (2023) · Medicinal Research Reviews · doi:10.1002/med.21971 · Cited by 207
Hydrogel drug delivery systems for minimally invasive local immunotherapy of cancer
Mikhail, A. S., Morhard, R., Mauda-Havakuk, M., Kassin, M., Arrichiello, A., & Wood, B. J. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115083 · Cited by 207
Guo, J., Yu, Z., Das, M., & Huang, L. (2020) · ACS Nano · doi:10.1021/acsnano.0c01676 · Cited by 203
Lipid nanoparticles for siRNA delivery in cancer treatment
El Moukhtari, S. H., Garbayo, E., Amundarain, A., Pascual-Gil, S., Carrasco-León, A., Prosper, F., Agirre, X., & Blanco-Prieto, M. J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.07.054 · Cited by 202
Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles
Kishimoto, T. K., Ferrari, J. D., LaMothe, R. A., Kolte, P. N., Griset, A. P., O'Neil, C., Chan, V., Browning, E., Chalishazar, A., Kuhlman, W., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.135 · Cited by 201
Tumor Ablation and Therapeutic Immunity Induction by an Injectable Peptide Hydrogel
Jin, H., Wan, C., Zou, Z., Zhao, G., Zhang, L., Geng, Y., Chen, T., Huang, A., Jiang, F., Feng, J.-P., et al. (2018) · ACS Nano · doi:10.1021/acsnano.7b08148 · Cited by 201
Self-citationGold Complexes in Anticancer Therapy: From New Design Principles to Particle‐Based Delivery Systems
Moreno‐Alcántar, G., Picchetti, P., & Casini, A. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202218000 · Cited by 200
Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics
Shi, P., Cheng, Z., Zhao, K., Chen, Y., Zhang, A., Gan, W., & Zhang, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01826-1 · Cited by 200
Pathobiology and Diagnosis of Multiple Myeloma
Brigle, K., & Rogers, B. (2017) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2017.05.012 · Cited by 199
Mountzios, G., Remon, J., Hendriks, L. E. L., García-Campelo, R., Rolfo, C., Van Schil, P., Forde, P. M., Besse, B., Subbiah, V., Reck, M., et al. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00794-7 · Cited by 199
Engineered Hydrogels in Cancer Therapy and Diagnosis
Sepantafar, M., Maheronnaghsh, R., Mohammadi, H., Radmanesh, F., Hasani-sadrabadi, M. M., Ebrahimi, M., & Baharvand, H. (2017) · Trends in Biotechnology · doi:10.1016/j.tibtech.2017.06.015 · Cited by 198
Smart Nanotherapeutic Targeting of Tumor Vasculature
Li, Z., Di, C., Li, S., Yang, X., & Nie, G. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00283 · Cited by 196
The Benefits and Risks of I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer
Van Nostrand, D. (2009) · Thyroid · doi:10.1089/thy.2009.1611 · Cited by 195
Song, W., Tiruthani, K., Wang, Y., Shen, L., Hu, M., Dorosheva, O., Qiu, K., Kinghorn, K. A., Liu, R., & Huang, L. (2018) · Advanced Materials · doi:10.1002/adma.201805007 · Cited by 194
Dong, Y., Li, W., Gu, Z., Xing, R., Ma, Y., Zhang, Q., & Liu, Z. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201904860 · Cited by 194
Han, L., Tang, C., & Yin, C. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.05.001 · Cited by 188
Song, Y., Tang, C., & Yin, C. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.017 · Cited by 188
Dmitrieva-Posocco, O., Dzutsev, A., Posocco, D. F., Hou, V., Yuan, W., Thovarai, V., Mufazalov, I. A., Gunzer, M., Shilovskiy, I. P., Khaitov, M. R., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.11.015 · Cited by 188
Neutrophil hitchhiking for drug delivery to the bone marrow
Luo, Z., Lu, Y., Shi, Y., Jiang, M., Shan, X., Li, X., Zhang, J., Qin, B., Liu, X., Guo, X., et al. (2023) · Nature Nanotechnology · doi:10.1038/s41565-023-01374-7 · Cited by 187
Nanoparticle‐Based Photothermal Therapy for Breast Cancer Noninvasive Treatment
Xiong, Y., Rao, Y., Hu, J., Luo, Z., & Chen, C. (2025) · Advanced Materials · doi:10.1002/adma.202305140 · Cited by 187
Rapamycin-Loaded Biomimetic Nanoparticles Reverse Vascular Inflammation
Boada, C., Zinger, A., Tsao, C., Zhao, P., Martinez, J. O., Hartman, K., Naoi, T., Sukhovershin, R., Sushnitha, M., Molinaro, R., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.315185 · Cited by 186
Designing Core–Shell Gold and Selenium Nanocomposites for Cancer Radiochemotherapy
Chang, Y., He, L., Li, Z., Zeng, L., Song, Z., Li, P., Chan, L., You, Y., Yu, X.-F., Chu, P. K., et al. (2017) · ACS Nano · doi:10.1021/acsnano.7b01346 · Cited by 185
Dexamethasone nanomedicines for COVID-19
Lammers, T., Sofias, A. M., van der Meel, R., Schiffelers, R., Storm, G., Tacke, F., Koschmieder, S., Brümmendorf, T. H., Kiessling, F., & Metselaar, J. M. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0752-z · Cited by 185
Yue, C., Zhang, C., Alfranca, G., Yang, Y., Jiang, X., Yang, Y., Pan, F., Fuente, J. M. D. L., & Cui, D. (2016) · Theranostics · doi:10.7150/thno.14101 · Cited by 184
Xu, Y., Xiong, J., Sun, X., & Gao, H. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.11.001 · Cited by 184
Self-citationNovel nanomedicines to overcome cancer multidrug resistance
Su, Z., Dong, S., Zhao, S.-C., Liu, K., Tan, Y., Jiang, X., Assaraf, Y. G., Qin, B., Chen, Z.-S., & Zou, C. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100777 · Cited by 182
Functionalized liposomes for targeted breast cancer drug delivery
Nel, J., Elkhoury, K., Velot, É., Bianchi, A., Acherar, S., Francius, G., Tamayol, A., Grandemange, S., & Arab-Tehrany, E. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.12.027 · Cited by 182
Carbon Nanotubes Enhance CpG Uptake and Potentiate Antiglioma Immunity
Zhao, D., Alizadeh, D., Zhang, L., Liu, W., Farrukh, O., Manuel, E., Diamond, D. J., & Badie, B. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2444 · Cited by 181
Kalimuthu, K., Lubin, B.-C., Bazylevich, A., Gellerman, G., Shpilberg, O., Luboshits, G., & Firer, M. A. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0362-1 · Cited by 181
Matias, D., Balça-Silva, J., da Graça, G. C., Wanjiru, C. M., Macharia, L. W., Nascimento, C. P., Roque, N. R., Coelho-Aguiar, J. M., Pereira, C. M., Dos Santos, M. F., et al. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00235 · Cited by 180
Zhong, X., Wang, X., Zhan, G., Tang, Y., Yao, Y., Dong, Z., Hou, L., Zhao, H., Zeng, S., Hu, J., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b03682 · Cited by 180
Lu-Emerson, C., Duda, D. G., Emblem, K. E., Taylor, J. W., Gerstner, E. R., Loeffler, J. S., Batchelor, T. T., & Jain, R. K. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.9575 · Cited by 179
Prostate-Specific Membrane Antigen Targeted Gold Nanoparticles for Theranostics of Prostate Cancer
Mangadlao, J. D., Wang, X., McCleese, C., Escamilla, M., Ramamurthy, G., Wang, Z., Govande, M., Basilion, J. P., & Burda, C. (2018) · ACS Nano · doi:10.1021/acsnano.8b00940 · Cited by 179
Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosis
Lee, Y., Ni, J., Beretov, J., Wasinger, V. C., Graham, P., & Li, Y. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01741-x · Cited by 179
Cong, Y., Xiao, H., Xiong, H., Wang, Z., Ding, J., Li, C., Chen, X., Liang, X., Zhou, D., & Huang, Y. (2018) · Advanced Materials · doi:10.1002/adma.201706220 · Cited by 178
Luo, L., Zhu, C., Yin, H., Jiang, M., Zhang, J., Qin, B., Luo, Z., Yuan, X., Yang, J., Li, W., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b00204 · Cited by 177
Explicating Exosomes: Reclassifying the Rising Stars of Intercellular Communication
Pluchino, S., & Smith, J. A. (2019) · Cell · doi:10.1016/j.cell.2019.03.020 · Cited by 177
Nanoparticle‐Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy
Zhen, W., Weichselbaum, R. R., & Lin, W. (2023) · Advanced Materials · doi:10.1002/adma.202206370 · Cited by 177
Biological roles and potential applications of immune cell‐derived extracellular vesicles
Wen, C., Seeger, R. C., Fabbri, M., Wang, L., Wayne, A. S., & Jong, A. Y. (2017) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2017.1400370 · Cited by 176
Zhuang, J., Tan, J., Wu, C., Zhang, J., Liu, T., Fan, C., Li, J., & Zhang, Y. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa683 · Cited by 176
Cited by
Exploring and bypassing resistance to targeted therapies in colorectal cancer
Favier, S., Xiong, W., Chalabi-Dchar, M., Chettab, K., Piercey, O., Wu, T., Fenouil, T., Albaret, M.-A., Jordheim, L. P., Diaz, J.-J., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118741 · Cited by 12
Tao, J., Ning, W., Lu, W., Wang, R., Zhou, H., Zhang, H., Xu, J., Wang, S., Teng, Z., & Wang, L. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.058 · Cited by 10
Self-citation
Metadata
- Authors
- Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2024-08-12
- Volume
- 9
- Issue
- 1
- Pages
- 200-200
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W4401497204
- Cited by
- 558
- References
- 1,028
- FWCI
- 58.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.